Contemporary Concise Review 2023: Asthma.
John PolitisPhilip G BardinPaul LeongPublished in: Respirology (Carlton, Vic.) (2024)
Asthma research and management needs to meet the priorities of the end user-patients, carers and clinicians. A better understanding of the natural history of asthma and the progression of disease has highlighted the importance of early identification of patients with asthma and the potential role of early intervention. Management of mild asthma requires a consistent approach with the same detail and consideration used when managing severe disease. Evidence around treatable traits approaches continues to evolve, supporting the role of a personalized medicine in asthma. Oral corticosteroid (OCS) stewardship continues to be an urgent issue in asthma management. Strategies to taper OCS doses and the implementation of biologic therapies for their steroid sparing benefits will be important steps to address this problem. The concept of remission in asthma provides an ambitious target and treatment outcome.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- allergic rhinitis
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- rheumatoid arthritis
- cystic fibrosis
- palliative care
- ejection fraction
- prognostic factors
- gene expression
- risk assessment
- climate change
- disease activity
- drug induced
- bioinformatics analysis